Risperidone in Situ Microparticle (ISM)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Risperidone in Situ Microparticle (ISM), covering 2022-02-04 to 2022-02-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute Schizophrenia [Phase 3]